MSD Licensing - Combining Our Strengths, Sharing Our Succe

Licensing

European Group

MSD Licensing Photos

Welcome!
At MSD UK, a subsidiary of Merck & Co. Inc., located in Whitehouse Station, NJ, we are strongly committed to partnership success. We recognise that the greatest achievements are not reached alone. They are the result of teamwork.

The philosophy of great achievements through teamwork is not new to us. We have a long tradition of successful partnerships. Alliances with innovative partners are an integral and essential part of our long-term business and research strategy. Our goal is for our partners and us to work together to accelerate the successful development and commercialisation of breakthrough products that can bring meaningful improvements to the lives of patients.

We understand that you have unique strengths to identify innovative therapeutic approaches. We are seeking partners with high quality science and subject matter, and most importantly the enthusiasm to collaborate with us and share a vision to bring the best medicine to patients worldwide.

"We are serious about our commitment to strategic alliances. Our goal is for our partners and us to remain in the forefront of turning scientific breakthroughs into medicines that make a difference. We have established a clear path to partnering, and invite you to explore the combination of your strengths with ours, and the successes we may share."

Mervyn Turner, Ph.D.
Senior Vice President
Worldwide Licensing and External Research
Merck & Co. Inc.

"Merck is a global company committed to doing drug discovery research of the highest quality in its own laboratories across the world. The role of our licensing and external research team is to put this internal effort together with the best research done outside Merck, to ensure we are continually able to market cutting-edge medicines to treat those diseases where there is real medical need."

Raymond G. Hill, Ph.D.
FMedSci
Executive Director and Head

"Licensing and collaborative research form a vital part of our mission to bring to the market new medicines that improve the health and well being of patients. We are committed to collaborations with biotech companies and academic institutions as a key way of expanding our internal strength in discovery and development. We encourage you to contact our European Licensing and External Research group to explore how we might work together to reinforce our joint commitment to producing better medicines for patients the world over."

Stefan Oschmann
President Human Health-EMEA & Canada

This site is intended for residents of the United Kingdom. Registered in England No 820771